Nov 25 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* HY LOSS AFTER TAX ATTRIBUTABLE NZ$5.1 MILLION VERSUS LOSS
NZ$13.5 MILLION
* HY REVENUE FROM ORDINARY ACTIVITIES – PRODUCT SALES UP 96%
TO
NZ$17.7 MILLION
* UPGRADED FY22 PRODUCT REVENUE GUIDANCE (ON CONSTANT
CURRENCY
BASIS) TO NZ$34-37 MILLION
* EXPECTS PRODUCT GROSS MARGINS TO CONTINUE TO IMPROVE, TO
BE
BETWEEN 73-75% FOR FY22
* CONSTRUCTION OF AROA'S SECOND MANUFACTURING FACILITY
EXPECTED TO
COMPLETE IN CY21
Source text for Eikon: ID:nASX4N4ffs
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))